Progether - Your Prostate Cancer Network

Name

Progether - Your Prostate Cancer Network

Website

https://progether.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Personal Health Records / Patient Health Tracking

NAICS

Software Publishers (513210)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF)

Keywords

• Prostate cancer tracking
• Personal health records
• PSA monitoring
• Patient health tracking
• Cancer care management

Headquarters

HQ city

Moss

HQ country

Norway

HQ region

Europe

Markets served

GTM type

B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Undisclosed Revenue Model: The revenue model for Progether is not publicly disclosed on the website. The platform appears to be in early stages with no visible pricing, subscription tiers, or monetization mechanisms described in the available source content.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Progether is a web-based personal health record platform that enables prostate cancer patients to log, track, and visualize their medical data over time. The application supports recording PSA values, diagnostic test results (biopsy, imaging, testosterone), and treatment information (radiation, surgery, drugs, active surveillance, focal therapy, watchful waiting), with data export in PDF format and multi-language support in English, German, and Norwegian.

Product overview

Progether is a single unified web-based personal health record platform designed specifically for prostate cancer patients. The product enables users to add and track PSA values, diagnostic test results (prostate biopsy, imaging tests, testosterone values), and treatment information (radiation, surgical treatment, drugs, active surveillance, focal therapy, watchful waiting). The platform supports data export, PDF printing, and visual overview features. Available in English, German, and Norwegian languages.

Differentiator

Problem solved

Functional benefit

Products and services

• Progether

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• MyChart (Epic): Epic's patient-facing portal used by hundreds of US health systems to give patients online access to test results, diagnoses, and visit summaries. It is the dominant general-purpose personal health record and directly overlaps with Progether's core function of letting patients view and share their own clinical data.
• Apple Health / Health Records: Apple's platform gives iOS users a consolidated personal health record across participating hospital systems and labs, including lab-value trending. The dominant general-purpose PHR reachable from a smartphone, directly competing for the same use case on iOS in Europe.
• PatientsLikeMe: Long-standing patient community and self-tracking platform across many conditions, including cancer. Comparable as patient-directed outcome and treatment tracking, with a much larger disease-agnostic footprint.

Emerging players

• OncoPower: Cancer patient app for tracking side effects, medications, and outcomes while connecting patients with peers. Comparable as a condition-specific (cancer) patient engagement platform with similar tracking-first value proposition.
• Kaiku Health: Digital health platform for cancer patient monitoring used by hospitals in Europe, with symptom and treatment tracking. Comparable through patient-driven cancer tracking, but provisioned by clinicians rather than direct-to-consumer.

Direct peers

• Belong.Life: Mobile-first cancer patient app offering personalized information, community, and tracking of treatments and side effects. Closely comparable to Progether in being a disease-specific (cancer) patient engagement and tracking tool, though broader across malignancies.
• Ciitizen: Patient-mediated health records platform that helps patients collect, organize, and share medical records. Like Progether, it targets specific patient populations (notably oncology) with a consumer-driven record model and PDF/share-with-doctor workflows.
• Medisafe: Direct-to-consumer medication management and personal health tracking app. Closely comparable as a patient-owned, consumer PHR with treatment tracking and multi-language support.
• CareZone: Consumer-facing personal health record focused on medication and symptom tracking with sharing features. Comparable as a direct-to-consumer patient health-tracking platform, though broader in scope than prostate-only.

Others

• Movember Foundation: Global men's health charity including prostate cancer programs, education, and patient tools. Not a direct product competitor, but a thematically comparable ecosystem actor whose own patient resources set user expectations for prostate-cancer digital tools.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/progether
• Facebookfacebook.com/Progether
• LinkedInlinkedin.com/company/progether

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Progether - Your Prostate Cancer Network